Systems Manager, Digital Quality

OXB is a quality and innovation-led viral vector CDMO that enables its clients to deliver life-changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, OXB has more than 30 years of experience in viral vectors, the driving force behind the majority of gene therapies. Cell and gene therapy is the treatment of disease by the delivery of therapeutic genetic material (DNA or RNA), into a patient’s cells. One highly effective approach to delivering genetic information is to re-engineer existing viruses to be safe delivery vehicles (vectors) to insert the genetic material into patients’ cells. This can be achieved either by directly administering the vector to the patient (often referred to as in vivo gene therapy), or by first introducing the genetic material to cells or tissue outside of the body, before administering the cells or tissue into the patient (often referred to as ex vivo gene therapy or gene-modified cell therapy). OXB collaborates with some of the world's most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. OXB's world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods and depth of regulatory expertise. Join Us in Changing Lives At OXB, our people are at the heart of everything we do. We’re on a mission to enable life-changing therapies to reach patients around the world—and we’re looking for passionate individuals who embody our core values every day: Responsible, Responsive, Resilient, and Respectful. Following the expansion of our US footprint with the acquisition of a new commercial-scale viral vector facility in Durham, North Carolina we have some new opportunities to join us. We’re currently recruiting for a Manager, Digital Quality Systems to join our Quality team. In this role, you will provide leadership and oversight for the quality and compliance of computerized and software systems, across all phases of the System Development Life Cycle. You will serve as the site Subject Matter Expert, for digital quality and data integrity, ensuring adherence to GxP requirements, corporate digital governance programs, and regulatory expectations, playing a key part in advancing our mission and making a real difference. Please note this is a full time role, based on site in Durham, NC. Your responsibilities in this role would be:

Provide quality oversight for computerized and software systems, across the SDLC. * Review and approve SDLC documentation, change controls, validation plans, URS, FRS, and related artifacts. * Oversee deviations, CAPAs, and continuous improvement activities associated with computerized systems. * Lead site initiatives to align, harmonize, and standardize digital systems governance with corporate programs (e.g., SDLC, Data Integrity, Risk Management, Periodic Reviews). * Act as the site Data Integrity steward, ensuring adherence to Resilience’s DI program and implementing DI controls for procured and in-house systems. * Maintain all digital systems in a state of inspection readiness. * Present and defend digital quality and data integrity programs and associated verification artifacts during client audits and regulatory inspections. * Support internal audits, customer audits, and regulatory inspections. * Provide guidance to SMEs and site stakeholders on maintaining compliant and inspection-ready digital systems. * Serve as liaison between site functions (Tech Ops, QA, Validation) and central dQ/DI functions. * Represent the site in quality leadership forums, site Quality Review Board, and corporate governance boards to adopt corporate digital quality and DI standards. * Establish, monitor, and report on site-based dQ/DI KPIs to site and corporate leadership. * Lead/assist with vendor audits and oversee risk-based digital system validation assessments. We are Looking For: * Bachelor’s degree or higher in IT, Computer Systems, Life Sciences, Engineering, or a related field. * Minimum of 5-7 years in the pharmaceutical/biotechnology industry, including IT compliance, digital quality, or computerized systems. * Hands-on experience implementing and managing GxP-compliant computerized system quality programs (COTS and custom systems). * Demonstrated experience designing and enforcing data integrity controls in computerized systems. * Experience managing high-performance teams and influencing cross-functional stakeholders. * Familiarity with AI/ML, automation, and next-generation laboratory platforms is a plus. * Comprehensive knowledge of global GMP regulations and guidance, including FDA, EU, ICH, GLP, GDocP, GDP, and GCP. * Strong experience in reviewing and approving system life cycle documentation, validation plans, change controls, and other digital quality artifacts. This role does not offer sponsorship for work authorization. External applicants must be eligible to work in the United States. About Us: OXB is a quality and innovation-led viral vector CDMO with a mission to enable its clients to deliver life changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, we have more than 30 years of experience in viral vectors; the driving force behind the majority of gene therapies. OXB collaborates with some of the world’s most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. OXB’s world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods, and depth of regulatory expertise. Why Join Us?

• 💸 Competitive total reward packages
• 🧘 Wellbeing programs that support your mental and physical health
• 🚀 Career development opportunities to help you grow and thrive
• 🤝 Supportive, inclusive, and collaborative culture
• 🧪 State-of-the-art labs and manufacturing facilities
• 🌍 A company that lives its values: Responsible, Responsive, Resilient, Respect

We want you to feel inspired every day. At OXB, we’re future-focused and growing fast. We succeed together—through passion, commitment, and teamwork. Ready to Make a Difference? Oxford Biomedica is a quality and innovation-led viral vector CDMO that enables its clients to deliver life-changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, Oxford Biomedica has more than 25 years of experience in viral vectors, the driving force behind the majority of gene therapies. Cell and gene therapy is the treatment of disease by the delivery of therapeutic genetic material (DNA or RNA), into a patient’s cells. One highly effective approach to delivering genetic information is to re-engineer existing viruses to be safe delivery vehicles (vectors) to insert the genetic material into patients’ cells. This can be achieved either by directly administering the vector to the patient (often referred to as in vivo gene therapy), or by first introducing the genetic material to cells or tissue outside of the body, before administering the cells or tissue into the patient (often referred to as ex vivo gene therapy or gene-modified cell therapy). Oxford Biomedica collaborates with some of the world's most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. Oxford Biomedica's world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods and depth of regulatory expertise.